ArrowMark Colorado Holdings’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-2,027
| Closed | -$1.02M | – | 316 |
|
|
2019
Q2 | $1.02M | Sell |
2,027
-55
| -3% | -$27.6K | 0.01% | 276 |
|
|
2019
Q1 | $2.07M | Sell |
2,082
-57,561
| -97% | -$57.2M | 0.02% | 243 |
|
|
2018
Q4 | $51.8M | Sell |
59,643
-469
| -0.8% | -$407K | 0.54% | 64 |
|
|
2018
Q3 | $62.1M | Buy |
60,112
+9,872
| +20% | +$10.2M | 0.52% | 61 |
|
|
2018
Q2 | $46.2M | Sell |
50,240
-7,161
| -12% | -$6.58M | 0.42% | 84 |
|
|
2018
Q1 | $56M | Sell |
57,401
-68,472
| -54% | -$66.8M | 0.56% | 64 |
|
|
2017
Q4 | $57M | Buy |
125,873
+14,844
| +13% | +$6.72M | 0.58% | 62 |
|
|
2017
Q3 | $45.9M | Buy |
111,029
+27,708
| +33% | +$11.5M | 0.52% | 65 |
|
|
2017
Q2 | $29.2M | Buy |
83,321
+6,060
| +8% | +$2.12M | 0.36% | 87 |
|
|
2017
Q1 | $39.7M | Buy |
77,261
+14,837
| +24% | +$7.62M | 0.54% | 65 |
|
|
2016
Q4 | $22.2M | Buy |
62,424
+9,611
| +18% | +$3.41M | 0.35% | 89 |
|
|
2016
Q3 | $28.2M | Buy |
52,813
+2,681
| +5% | +$1.43M | 0.51% | 68 |
|
|
2016
Q2 | $28.2M | Buy |
50,132
+16,130
| +47% | +$9.08M | 0.57% | 60 |
|
|
2016
Q1 | $16.2M | Buy |
34,002
+4,541
| +15% | +$2.16M | 0.36% | 87 |
|
|
2015
Q4 | $19.5M | Buy |
29,461
+10,563
| +56% | +$6.97M | 0.53% | 64 |
|
|
2015
Q3 | $14.9M | Buy |
18,898
+13,951
| +282% | +$11M | 0.41% | 76 |
|
|
2015
Q2 | $6.53M | Buy |
4,947
+62
| +1% | +$81.8K | 0.16% | 132 |
|
|
2015
Q1 | $5.08M | Buy |
+4,885
| New | +$5.08M | 0.13% | 140 |
|